Peter Bui

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFκB and AhR and EGFR–ERK pathway

HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species

Flavonoids as natural phenolic compounds and their role in therapeutics: an overview

Targeting hypoxia in cancer therapy

Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance

Cell cycle proteins as promising targets in cancer therapy

The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia

Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?

SIN3A, Generally Regarded as a Transcriptional Repressor, Is Required for Induction of Gene Transcription by the Aryl Hydrocarbon Receptor

Efficient Hypoxic Activation of the Anticancer Agent AQ4N by CYP2S1 and CYP2W1

Selective C H bond functionalization with engineered heme proteins: new tools to generate complexity

Targeting apoptosis in cancer therapy

Palbociclib triggers apoptosis in bladder cancer cells by Cdk2-induced Rad9-mediated reorganization of the Bak.Bcl-xl complex

Resveratrol Enhances Solar UV‐induced Responses in Normal Human Epidermal Keratinocytes

Biological activity of piceatannol: Leaving the shadow of resveratrol

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Aryl Hydrocarbon Receptor Control of Adaptive Immunity

Verbascoside — A review of its occurrence, (bio)synthesis and pharmacological significance

The history and future of targeting cyclin-dependent kinases in cancer therapy

A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

Formation and Cleavage of C–C Bonds by Enzymatic Oxidation–Reduction Reactions

Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines

Role of Epigenetic Mechanisms in Differential Regulation of the Dioxin-Inducible Human CYP1A1 and CYP1B1 Genes

Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli

Resveratrol Inhibits Dioxin-Induced Expression of Human CYP1A1 and CYP1B1 by Inhibiting Recruitment of the Aryl Hydrocarbon Receptor Complex and RNA Polymerase II to the Regulatory Regions of the Corresponding Genes

Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol

2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion

Human CYP2S1 Metabolizes Cyclooxygenase- and Lipoxygenase-Derived Eicosanoids

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.